Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module

The aim of this study was to develop and validate a symptom inventory for patients with head and neck cancer and to assess the occurrence and severity of symptoms, the overall symptom burden, and the interference the symptoms cause in daily life.

[1]  M. Aldenderfer Cluster Analysis , 1984 .

[2]  C. Cleeland,et al.  Assessing symptom distress in cancer patients , 2000 .

[3]  M. Lynn Determination and quantification of content validity. , 1986, Nursing research.

[4]  C. Cleeland,et al.  Content validity of self-report measurement instruments: an illustration from the development of the Brain Tumor Module of the M.D. Anderson Symptom Inventory. , 2005, Oncology nursing forum.

[5]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[6]  A. Bezjak,et al.  A structured review of quality of life instruments for head and neck cancer patients , 2001, Head & neck.

[7]  U. S. Department of Health and Human Services FDA Cen Research,et al.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance , 2006, Health and quality of life outcomes.

[8]  C. Finizia,et al.  Quality of life and voice in patients with laryngeal carcinoma: A posttreatment comparison of laryngectomy (salvage surgery) versus radiotherapy , 1998, The Laryngoscope.

[9]  Katherine R. Edwards,et al.  When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function , 1995, Pain.

[10]  R. Frankowski,et al.  The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. , 2001, Archives of otolaryngology--head & neck surgery.

[11]  R. Weichselbaum,et al.  Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Cleeland,et al.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. , 2000, Cancer.

[13]  E. B. Andersen,et al.  Modern factor analysis , 1961 .

[14]  C. Cleeland,et al.  When is it justified to treat symptoms? Measuring symptom burden. , 2002, Oncology.

[15]  L. Dawson,et al.  Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.

[16]  M. Gilbert,et al.  Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT) , 2006, Journal of Neuro-Oncology.

[17]  J. H. Ward Hierarchical Grouping to Optimize an Objective Function , 1963 .

[18]  M. List,et al.  Functional outcomes in head and neck cancer. , 2004, Seminars in radiation oncology.

[19]  James S. Brown,et al.  The impact of neck dissection on health-related quality of life. , 2004, Archives of otolaryngology--head & neck surgery.

[20]  G. Weinstein,et al.  Preliminary Investigation of Symptom Distress in the Head and Neck Patient Population: Validation of a Measurement Instrument , 2006, American journal of clinical oncology.

[21]  J. Gavilán,et al.  Psychosocial Adjustment after Laryngeal Cancer Surgery , 1999, The Annals of otology, rhinology, and laryngology.

[22]  K. Bjordal,et al.  Quality of Life and Head and Neck Cancer: A 5 Year Prospective Study , 2005, The Laryngoscope.

[23]  C. Cleeland,et al.  The rapid assessment of fatigue severity in cancer patients , 1999, Cancer.

[24]  J. Farrar,et al.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[25]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[26]  E. Vokes,et al.  The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: A study of utility and validity , 1996, Cancer.